跳至主要内容
临床试验/CTRI/2024/10/076031
CTRI/2024/10/076031尚未招募2/3 期

A Randomized Controlled Clinical Trial To Compare The Efficacy Of Chaturbeej Churna And Latakaranj Churna For Garbhashay Shodhan In Sutikavastha

Tilak Ayurved Mahavidyalay1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年11月8日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
Decrease in fundal height of uterus and yonigat strav

研究概览

简要总结

The study will be intervened by the treatment of Chaturbeej Churna and Latakaranj Churna to group A and group B respectively. The efficacy of the therapy will be assessed on the basis of subjective criteria for statistical analysis. Scoring will be designed according to the severity of symptoms. The subjective gradation of symptoms will be done as follows and the intensity of each symptom will be calculated before treatment, after treatment and after follow up. The effect of treatment result will be assessed in regards to clinical signs and symptoms on the basis of grading and scoring system. The signs and symptoms will be assessed by adopting the suitable scoring method.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • All primipara,multipara women will be included.

排除标准

  • High risk pregnancies like severe anaemia,GDM,PIH, Pre-eclampsia, Eclampsia.

结局指标

主要结局

Decrease in fundal height of uterus and yonigat strav

时间窗: 7th and 15th day

次要结局

  • Improvement in uterine consistency(30th day and 45th day)

研究者

发起方
Tilak Ayurved Mahavidyalay
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Shivani Pandurang Kale

Tilak Ayurved Mahavidyalay

研究点 (1)

Loading locations...

相似试验